Deals
Generex Biotechnology Raises $2M in Conv Preferred at 25% Discount.
|
Generex Biotechnology Corporation (GNBT) announced that it has raised $2,075,000 in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.03 per share, an approximate 25% discount to the market price ($0.04) of GNBT at deal announcement. A series of 69,166,667 60-Month Warrants with an exercise price of $0.03 per share (25% discount) was issued to the investors in this transaction. The transaction is expected to close on March 27, 2014. via PlacementTracker.